The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis
Abstract
Multidrug-resistant tuberculosis (MDR) is perceived as a growing hazard to human health worldwide. Judgments about the true scale of the problem, and strategies for containing it, need to come from a balanced appraisal of the epidemiological evidence. We conclude in this review that MDR is, and will probably remain, a locally severe problem; that epidemics can be prevented by fully exploiting the potential of standard short-course chemotherapy (SCC) based on cheap and safe first-line drugs; and that best-practice SCC may even reduce the incidence of MDR where it has already become endemic. On the basis of the available, imperfect data, we recommend a three-part response to the threat of MDR: widespread implementation of SCC as the cornerstone of good tuberculosis control, improved resistance testing and surveillance, and the careful introduction of second-line drugs after a sound evaluation of cost, effectiveness, and feasibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sreevatsan, S., Pan, X., Stockbauer, K. E., Connell, N. D., Kreiswirth, B. N., Whittam, T. S., & Musser, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9869 · Cited by 1,024
Global Trends in Resistance to Antituberculosis Drugs
Espinal, M. A., Laszlo, A., Simonsen, L., Boulahbal, F., Kim, S. J., Reniero, A., Hoffner, S., Rieder, H. L., Binkin, N., Dye, C., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441706 · Cited by 671
Self-citationEspinal, M. A., Kim, S. J., Suarez, P. G., Kam, K. M., Khomenko, A. G., Migliori, G. B., Baéz, J., Kochi, A., Dye, C., & Raviglione, M. C. (2000) · JAMA · doi:10.1001/jama.283.19.2537 · Cited by 507
Self-citationThe intrinsic transmission dynamics of tuberculosis epidemics
Blower, S. M., Mclean, A. R., Porco, T. C., Small, P. M., Hopewell, P. C., Sanchez, M. A., & Moss, A. R. (1995) · Nature Medicine · doi:10.1038/nm0895-815 · Cited by 471
Control Strategies for Tuberculosis Epidemics: New Models for Old Problems
Blower, S. M., Small, P. M., & Hopewell, P. C. (1996) · Science · doi:10.1126/science.273.5274.497 · Cited by 350
Van Soolingen, D. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00772.x · Cited by 350
Cohn, D. L., Bustreo, F., & Raviglione, M. C. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s121 · Cited by 340
Self-citationVernon, A., Burman, W., Benator, D., Khan, A., & Bozeman, L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11467-8 · Cited by 308
Frieden, T. R. (1996) · JAMA · doi:10.1001/jama.276.15.1229 · Cited by 295
Molecular Epidemiology of Tuberculosis in the Netherlands: A Nationwide Study from 1993 through 1997
van Soolingen, D., Borgdorff, M. W., de Haas, P. E. W., Sebek, M. M. G. G., Veen, J., Dessens, M., Kremer, K., & van Embden, J. D. A. (1999) · The Journal of Infectious Diseases · doi:10.1086/314930 · Cited by 285
Guidelines for the Management of Drug-resistant Tuberculosis
Crofton, S. J., Chaulet, P., Maher, D., Grosset, J. H. E., Harris, W. T., Horne, N., Iseman, M. D., & Watt, B. (1997) · Cited by 270
Farmer, P., & Kim, J. Y. (1998) · BMJ · doi:10.1136/bmj.317.7159.671 · Cited by 256
Mycobacterium tuberculosis Beijing Genotype Emerging in Vietnam
Anh, D. D., Borgdorff, M. W., Van, L. N., Lan, N. T. N., van Gorkom, T., Kremer, K., & van Soolingen, D. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0603.000312 · Cited by 249
The Treatment of Multidrug-Resistant Tuberculosis in Turkey
Tahaoğlu, K., Törün, T., Sevim, T., Ataç, G., Kir, A., Karasulu, L., Özmen, İ., & Kapaklı, N. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450303 · Cited by 248
Mahmoudi, A. (1993) · JAMA · doi:10.1001/jama.270.1.65 · Cited by 219
Determinants of drug-resistant tuberculosis: analysis of 11 countries.
Espinal, M., Laserson, K., Camacho, M., Fusheng, Z., Kim, S. J., Tlali, R. E., Smith, I., Suarez, P. G., Antunes, M. L., George, A., et al. (2001) · PubMed · Cited by 203
Self-citationFrieden, T. R. (1996) · JAMA · doi:10.1001/jama.1996.03540150031027 · Cited by 199
Spread of Drug-Resistant Pulmonary Tuberculosis in Estonia
Krüüner, A., Hoffner, S. E., Sillastu, H., Danilovits, M., Levina, K., Svenson, S. B., Ghebremichael, S., Koivula, T., & Källenius, G. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.9.3339-3345.2001 · Cited by 190
Will tuberculosis become resistant to all antibiotics?
Dye, C., & Espinal, M. (2001) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2000.1328 · Cited by 148
Self-citationBorgdorff, M. W., Nagelkerke, N. J. D., van Soolingen, D., de Haas, P. E. W., Veen, J., & van Embden, J. D. A. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009433 · Cited by 139
Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis.
Girardi, E., Raviglione, M. C., Antonucci, G., Godfrey‐Faussett, P., & Ippolito, G. (2000) · PubMed · Cited by 139
Self-citationResponding to Market Failures in Tuberculosis Control
Gupta, R., Kim, J. Y., Espinal, M., Caudron, J.-M., Pécoul, B., Farmer, P. E., & Raviglione, M. C. (2001) · Science · doi:10.1126/science.1061861 · Cited by 136
Self-citationAgerton, T., Valway, S. E., Blinkhorn, R., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/520187 · Cited by 127
Clinical Consequences and Transmissibility of Drug-Resistant Tuberculosis in Southern Mexico
García-García, M. D. L., Ponce‐de‐León, A., Jiménez-Corona, M. E., Jiménez-Corona, A., Palacios-Martínez, M., Balandrano, S., Ferreyra-Reyes, L. D., Juárez-Sandino, L., Sifuentes‐Osornio, J., Olivera-Díaz, H., et al. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.5.630 · Cited by 125
Mycobacterium tuberculosisBeijing Genotype Strains Associated with Febrile Response to Treatment
van Crevel, R., Nelwan, R. H. H., de Lenne, W., Veeraragu, Y., van der Zanden, A. G., Amin, Z., van der Meer, J. W. M., & van Soolingen, D. (2001) · Emerging infectious diseases · doi:10.3201/eid0705.017518 · Cited by 121
Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice
Ordway, D. J., Sonnenberg, M. G., Donahue, S. A., Belisle, J. T., & Orme, I. M. (1995) · Infection and Immunity · doi:10.1128/iai.63.2.741-743.1995 · Cited by 120
Becerra, M. C., Freeman, J., Bayona, J. N., Shin, S. S., Kim, J. Y., Furin, J. J., Werner, B., Sloutsky, A., Timperi, R., Wilson, M. E., et al. (2000) · PubMed · Cited by 91
Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US
Taussig, J., Weinstein, B. D., Burris, S. C., & Jones, T. S. (2000) · AIDS · doi:10.1097/00002030-200006001-00007 · Cited by 80
(1999) · PubMed · Cited by 71
Laserson, K. F., Osório, L., Sheppard, J. D., Hernández, H., Benitez, A. M., Brim, S., Woodley, C. L., Hazbón, M. H., Villegas, M. V., Castaño, M. C., et al. (2000) · PubMed · Cited by 53
Kam, K. M., & Yip, C. W. (2001) · PubMed · Cited by 31
The molecular mechanisms of drug resistance in Mycobacterium tuberculosis
Takiff, H. E. (2000) · Resurgent and emerging infectious diseases · doi:10.1007/978-94-011-4084-3_6 · Cited by 16
Cited by
Gandhi, N. R., Nunn, P., Dheda, K., Schaaf, H. S., Zignol, M., van Soolingen, D., Jensen, P., & Bayona, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60410-2 · Cited by 1,018
Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
Seung, K. J., Keshavjee, S., & Rich, M. L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017863 · Cited by 805
“In the early 2000s, it was believed that resistance mutations conferred a loss of fitness, so the transmission of resistant strains would be selflimited (Dye et al. 2002; Cegielski 2010).”
BackgroundImmune Control of Tuberculosis by IFN-γ-Inducible LRG-47
MacMicking, J. D., Taylor, G. A., & McKinney, J. D. (2003) · Science · doi:10.1126/science.1088063 · Cited by 685
The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosis
Gagneux, S., Long, C. D., Small, P. M., Van, T., Schoolnik, G. K., & Bohannan, B. J. M. (2006) · Science · doi:10.1126/science.1124410 · Cited by 627
Ecology and evolution of Mycobacterium tuberculosis
Gagneux, S. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2018.8 · Cited by 599
Metadata
- Authors
- Dye, C., Williams, B. G., Espinal, M. A., & Raviglione, M. C.
- Venue
- Science
- Published
- 2002-03-15
- Volume
- 295
- Issue
- 5562
- Pages
- 2042-2046
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2092030365
- Cited by
- 314
- References
- 32
- FWCI
- 18.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.